Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes

By LabMedica International staff writers
Posted on 03 Jul 2025

Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. More...

It significantly heightens the risk of complications such as gestational hypertension, polyhydramnios, and cesarean delivery for the mother, while increasing the likelihood of birth asphyxia and long-term health conditions like obesity and diabetes in children. Early diagnosis and intervention are key to reducing these risks, yet current diagnostic methods often detect the disorder only after complications have begun to develop. In a new study, researchers identified early-pregnancy gut microbiota signatures that may serve as predictive biomarkers, paving the way for non-invasive early diagnosis of gestational diabetes.

In the study, researchers from Zhujiang Hospital of Southern Medical University (Guangzhou, China), along with collaborators, analyzed fecal microbiota from 61 pregnant women in their first trimester using 16S rRNA gene sequencing, a method that profiles bacterial communities at high resolution. They then correlated these microbiome profiles with oral glucose tolerance test results conducted between 24 to 28 weeks of gestation and with recorded clinical delivery outcomes. Through this process, the researchers were able to detect gut microbiota dysbiosis associated with the future onset of gestational diabetes. Using genus-level microbial markers, they developed an early diagnostic model designed to identify the condition well before traditional symptoms emerge.

The findings, published in Microbiology Spectrum, revealed significant differences in gut microbiota composition between women who developed gestational diabetes and those who did not. The diagnostic model demonstrated high predictive accuracy, supporting the potential of microbiome-based tools for early, non-invasive detection. The findings suggest that this approach could enable earlier intervention, offering better prevention and personalized care strategies to reduce adverse maternal and fetal outcomes. The researchers plan to refine and validate their model further across larger populations, with the long-term aim of integrating gut microbiota screening into routine prenatal care.

“These findings suggest that microbiota-based tools could enable early, non-invasive detection of gestational diabetes mellitus, offering new opportunities for prevention and personalized management,” wrote the study authors. “This research highlights the role of the gut microbiome in pregnancy and has important implications for improving maternal and fetal health outcomes.”


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Collection and Transport System
PurSafe Plus®
Gold Member
Hematology Analyzer
Medonic M32B
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Technology

view channel
Image: The SWITCH hybrid pipette is designed to simplify and accelerate pipetting tasks (Photo courtesy of INTEGRA)

Hybrid Pipette Combines Manual Control with Fast Electronic Aliquoting

Manual pipettes offer the control needed for delicate tasks such as mixing or supernatant removal, but typically fall short in repetitive workflows like aliquoting. Electronic pipettes solve this problem... Read more

Industry

view channel
Image: The partnership between OGT and QIAGEN unlocks a complete sample to report workflow for SureSeq NGS panels (Photo courtesy of OGT)

Qiagen and Oxford Gene Technology Partner on Sequencing Panel Interpretation

In clinical research, next-generation sequencing (NGS) panels provide essential insights for genetic analysis, but many laboratories face challenges in transforming raw sequencing data into clinically... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.